Literature DB >> 10077160

Examination of POU homeobox gene expression in human breast cancer cells.

T Jin1, D R Branch, X Zhang, S Qi, B Youngson, P E Goss.   

Abstract

Abnormal expression of homeobox genes may lead to the development of leukemias, lymphomas, and solid tumors. Expression of homeobox genes in mammary glands, however, has not been studied actively until recently. We have examined the expression of POU homeobox genes in human breast cancer cell lines and human breast tissue samples. Using a pair of degenerate primers for reverse transcription-polymerase chain reaction (RT-PCR) followed by DNA sequencing, we found that the human breast cancer cell line, MCF7, expresses at least 4 POU gene products: OCT1, OCT2, OCT3 and OCT11 (Skn-1a/i, Epoc-1). The expression of OCT1 and OCT2 in other human breast epithelial cell lines was further determined by Western blot analyses and electrophoretic mobility shift assay. We were unable to detect OCT11 in human breast cancer cell lines using the anti rat Skn-1a/i antibody, although the expression of this gene in both human breast cancer cell lines and human primary breast tumors was detected by RT-PCR. OCT3 is an embryonic transcription factor. We found that this gene is also expressed in human breast cancer cell lines and all human primary breast carcinomas examined, but not in normal human breast tissue. Taken together, we have shown that several POU genes are expressed in human breast epithelial cells. As OCT3 expression was detected only in the breast cancerous cells, this embryonic transcription factor could play an important role in mammary gland carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10077160     DOI: 10.1002/(sici)1097-0215(19990331)81:1<104::aid-ijc18>3.0.co;2-q

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  34 in total

1.  Alpha1 and beta1 integrins enhance the homing and differentiation of cultured prostate cancer stem cells.

Authors:  Satyanarayana Rentala; Prameela Devi Yalavarthy; Lakshmi Narasu Mangamoori
Journal:  Asian J Androl       Date:  2010-06-07       Impact factor: 3.285

Review 2.  Role of homeobox genes in normal mammary gland development and breast tumorigenesis.

Authors:  Hexin Chen; Saraswati Sukumar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

3.  NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53.

Authors:  Marie Zbinden; Arnaud Duquet; Aiala Lorente-Trigos; Sandra-Nadia Ngwabyt; Isabel Borges; Ariel Ruiz i Altaba
Journal:  EMBO J       Date:  2010-06-25       Impact factor: 11.598

Review 4.  The Oct1 transcription factor and epithelial malignancies: Old protein learns new tricks.

Authors:  Karina Vázquez-Arreguín; Dean Tantin
Journal:  Biochim Biophys Acta       Date:  2016-02-10

5.  Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity.

Authors:  Arvind Shakya; Robert Cooksey; James E Cox; Victoria Wang; Donald A McClain; Dean Tantin
Journal:  Nat Cell Biol       Date:  2009-02-15       Impact factor: 28.824

6.  A general mechanism for transcription regulation by Oct1 and Oct4 in response to genotoxic and oxidative stress.

Authors:  Jinsuk Kang; Matthew Gemberling; Mitsuhiro Nakamura; Frank G Whitby; Hiroshi Handa; William G Fairbrother; Dean Tantin
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

7.  The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.

Authors:  Peixiang Wang; Donald R Branch; Meenakshi Bali; Gilbert A Schultz; Paul E Goss; Tianru Jin
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

8.  POU4F1 is associated with t(8;21) acute myeloid leukemia and contributes directly to its unique transcriptional signature.

Authors:  J M Fortier; J E Payton; P Cahan; T J Ley; M J Walter; T A Graubert
Journal:  Leukemia       Date:  2010-04-08       Impact factor: 11.528

9.  OCT-4 expression in follicular and luteal phase endometrium: a pilot study.

Authors:  Eva-Katrin Bentz; Marina Kenning; Christian Schneeberger; Andrea Kolbus; Johannes C Huber; Lukas A Hefler; Clemens B Tempfer
Journal:  Reprod Biol Endocrinol       Date:  2010-04-22       Impact factor: 5.211

10.  EWS-Oct-4B, an alternative EWS-Oct-4 fusion gene, is a potent oncogene linked to human epithelial tumours.

Authors:  S Kim; B Lim; J Kim
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.